Data from Scotland’s Covid vaccination programme has revealed a possible small increase in the risk of a treatable and often mild bleeding disorder after the first dose of the AstraZeneca vaccine. Writing in Nature Medicine, the researchers estimate there are an additional 11 cases of ITP for every million doses of the AstraZeneca vaccine administered. Catching coronavirus itself carries a substantially higher risk of ITP. The study found weaker evidence for an increased risk of clots in the arteries and bleeding events after the AstraZeneca vaccine. “Even if the Oxford/AstraZeneca vaccine does have an increased risk of ITP, its benefit outweighs its risk.

Source: The Irish Times June 09, 2021 16:07 UTC